BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28119019)

  • 1. Identification and characterization of a protective antigen, PlpB of bovine Pasteurella multocida strain LZ-PM.
    Wei X; Wang Y; Luo R; Qian W; Sizhu S; Zhou H
    Dev Comp Immunol; 2017 Jun; 71():1-7. PubMed ID: 28119019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).
    Wu JR; Shien JH; Shieh HK; Chen CF; Chang PC
    Vaccine; 2007 May; 25(21):4140-8. PubMed ID: 17449151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and immunoprotective property of a 39-kDa PlpB protein of Pasteurella multocida.
    CHOMNAWANG MT; NABNUENGSAP J; KITTIWORAKARN J; PATHANASOPHON P
    J Vet Med Sci; 2009 Nov; 71(11):1479-85. PubMed ID: 19959899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B:2.
    Tan HY; Nagoor NH; Sekaran SD
    Trop Biomed; 2010 Dec; 27(3):430-41. PubMed ID: 21399583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of Pasteurella multocida cell-free antigen and toxoid against challenge with toxigenic strains of pasteurella multocida in mice.
    Uchida C; Kimura Y; Kubota S; Sasaki O
    J Vet Med Sci; 2003 Jun; 65(6):737-40. PubMed ID: 12867737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice.
    Okay S; Ozcengiz E; Ozcengiz G
    Acta Microbiol Immunol Hung; 2012 Dec; 59(4):485-98. PubMed ID: 23195557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
    Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
    J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida.
    Shivachandra SB; Kumar A; Yogisharadhya R; Viswas KN
    Vaccine; 2014 Jan; 32(2):290-6. PubMed ID: 24280281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate vaccine antigens and genes in Pasteurella multocida.
    Adler B; Bulach D; Chung J; Doughty S; Hunt M; Rajakumar K; Serrano M; van Zanden A; Zhang Y; Ruffolo C
    J Biotechnol; 1999 Aug; 73(2-3):83-90. PubMed ID: 10486918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of porcine Pasteurella multocida ghost vaccine and examination of its immunogenicity against virulent challenge in mice.
    Ran X; Meng XZ; Geng HL; Chang C; Chen X; Wen X; Ni H
    Microb Pathog; 2019 Jul; 132():208-214. PubMed ID: 30980881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross-protective effect of the Cp39 adhesive proteins against avian Pasteurella multicida in mice].
    Borrathybay E; Peng Q; Yan F; He C; Nazierbieke W
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):360-6. PubMed ID: 20499641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane protein H for protective immunity against Pasteurella multocida.
    Lee J; Kim YB; Kwon M
    J Microbiol; 2007 Apr; 45(2):179-84. PubMed ID: 17483806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A:3 in mice.
    Okay S; Özcengiz E; Gürsel I; Özcengiz G
    Res Vet Sci; 2012 Dec; 93(3):1261-5. PubMed ID: 22727197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides.
    Tatum FM; Tabatabai LB; Briggs RE
    Avian Dis; 2009 Jun; 53(2):169-74. PubMed ID: 19630220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity and vaccine development in Pasteurella multocida infections.
    Adler B; Chancellor R; Homchampa P; Hunt M; Ruffolo C; Strugnell R; Wapling D
    J Biotechnol; 1996 Jan; 44(1-3):139-44. PubMed ID: 8717397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida.
    Homchampa P; Strugnell RA; Adler B
    Vaccine; 1997 Feb; 15(2):203-8. PubMed ID: 9066039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.
    Roier S; Fenninger JC; Leitner DR; Rechberger GN; Reidl J; Schild S
    Int J Med Microbiol; 2013 Jul; 303(5):247-56. PubMed ID: 23731905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of
    Fegan JE; Waeckerlin RC; Tesfaw L; Islam EA; Deresse G; Dufera D; Assefa E; Woldemedhin W; Legesse A; Akalu M; Bayissa B; Nguyen QH; Ng D; Ahn SK; Schryvers AB; Tefera TA; Moraes TF; Gray-Owen SD
    Front Immunol; 2024; 15():1392681. PubMed ID: 38835751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice.
    Dabo SM; Confer A; Montelongo M; York P; Wyckoff JH
    Vaccine; 2008 Aug; 26(34):4345-51. PubMed ID: 18598730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.